| Ticker |
BMY
|
| CIK | 0000014272 |
| SIC | 2834 |
| Sector | Manufacturing |
| Industry Category | Pharmaceutical Products |
| Industry Group | Pharmaceutical Preparations |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’We recently published a list of 10 Stocks to Watch as Trade Wars Begin. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks to watch as trade wars begin. Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC […] BMSCH announces Children’s Same Day Services centre in the USThe facility is designed to offer private care for children requiring regular, non-oncologic infusion therapies. BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?Bristol Myers' first-quarter performance and raised annual guidance are encouraging. However, we recommend investors to stay on the sidelines as generic competition for legacy drugs and recent pipeline setbacks weigh on the stock. 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-OffIt's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. With a volatile equity market and a potential recession looming due to the impact of tariffs, dividend stocks can help strengthen any portfolio. With that as a backdrop, let's consider four excellent income stocks that investors can buy amid the current sell-off: AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), Bristol Myers Squibb (NYSE: BMY), and Zoetis (NYSE: ZTS). Bristol-Myers Squibb First Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsBristol-Myers Squibb ( NYSE:BMY ) First Quarter 2025 Results Key Financial Results Revenue: US$11.2b (down 5.6% from 1Q... |
